SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 287 filers reported holding SAGE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5 | -54.5% | 239 | 0.0% | 0.00% | – |
| Q2 2023 | $11 | +10.0% | 239 | 0.0% | 0.00% | – |
| Q1 2023 | $10 | +11.1% | 239 | 0.0% | 0.00% | – |
| Q4 2022 | $9 | -99.9% | 239 | +8.6% | 0.00% | – |
| Q3 2022 | $9,000 | +28.6% | 220 | 0.0% | 0.00% | – |
| Q2 2022 | $7,000 | +16.7% | 220 | +27.9% | 0.00% | – |
| Q1 2022 | $6,000 | -14.3% | 172 | 0.0% | 0.00% | – |
| Q4 2021 | $7,000 | -22.2% | 172 | -14.4% | 0.00% | – |
| Q3 2021 | $9,000 | +28.6% | 201 | +73.3% | 0.00% | – |
| Q2 2021 | $7,000 | -22.2% | 116 | 0.0% | 0.00% | – |
| Q1 2021 | $9,000 | +12.5% | 116 | +18.4% | 0.00% | – |
| Q4 2020 | $8,000 | -55.6% | 98 | -66.4% | 0.00% | – |
| Q3 2020 | $18,000 | +125.0% | 292 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | 0.0% | 292 | 0.0% | 0.00% | – |
| Q1 2020 | $8,000 | -97.0% | 292 | -92.2% | 0.00% | -100.0% |
| Q4 2019 | $269,000 | -43.7% | 3,723 | +9.3% | 0.00% | -50.0% |
| Q3 2019 | $478,000 | -29.9% | 3,405 | -8.6% | 0.00% | -33.3% |
| Q2 2019 | $682,000 | -0.1% | 3,725 | -13.2% | 0.01% | 0.0% |
| Q1 2019 | $683,000 | +2176.7% | 4,291 | +1284.2% | 0.01% | – |
| Q4 2018 | $30,000 | -6.2% | 310 | +34.8% | 0.00% | – |
| Q3 2018 | $32,000 | -11.1% | 230 | 0.0% | 0.00% | – |
| Q2 2018 | $36,000 | -2.7% | 230 | 0.0% | 0.00% | – |
| Q1 2018 | $37,000 | – | 230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |